These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30462197)

  • 21. Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice.
    Liang Y; Lubkin M; Sheng H; Scislowski PW; Cincotta AH
    Biochim Biophys Acta; 1998 Oct; 1405(1-3):1-13. PubMed ID: 9784590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attempts to pharmacologically modulate prolactin levels and type 1 autoimmune diabetes in the non-obese diabetic (NOD) mouse.
    Durant S; Alves V; Coulaud J; El Hasnaoui A; Dardenne M; Homo-Delarche F
    J Autoimmun; 1995 Dec; 8(6):875-85. PubMed ID: 8824712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of glucose homeostasis and hepatic insulin resistance in ob/ob mice given oral molybdate.
    Reul BA; Becker DJ; Ongemba LN; Bailey CJ; Henquin JC; Brichard SM
    J Endocrinol; 1997 Oct; 155(1):55-64. PubMed ID: 9390006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice.
    Burcelin R; Kamohara S; Li J; Tannenbaum GS; Charron MJ; Friedman JM
    Diabetes; 1999 Jun; 48(6):1264-9. PubMed ID: 10342814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MKR mice are resistant to the metabolic actions of both insulin and adiponectin: discordance between insulin resistance and adiponectin responsiveness.
    Kim CH; Pennisi P; Zhao H; Yakar S; Kaufman JB; Iganaki K; Shiloach J; Scherer PE; Quon MJ; LeRoith D
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E298-305. PubMed ID: 16507604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice.
    Sreejayan N; Dong F; Kandadi MR; Yang X; Ren J
    Obesity (Silver Spring); 2008 Jun; 16(6):1331-7. PubMed ID: 18388893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of bromocriptine on insulin, growth hormone and prolactin responses to arginine in obesity.
    Maccario M; Grottoli S; Procopio M; Oleandri SE; Barberis A; Ciccarelli E; Camanni F; Ghigo E
    J Endocrinol Invest; 1996 Apr; 19(4):219-23. PubMed ID: 8862501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The estrogen receptor {alpha}-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms.
    Lundholm L; Bryzgalova G; Gao H; Portwood N; Fält S; Berndt KD; Dicker A; Galuska D; Zierath JR; Gustafsson JÅ; Efendic S; Dahlman-Wright K; Khan A
    J Endocrinol; 2008 Nov; 199(2):X1. PubMed ID: 18757549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus.
    Rahimian R; Masih-Khan E; Lo M; van Breemen C; McManus BM; Dubé GP
    Mol Cell Biochem; 2001 Aug; 224(1-2):29-37. PubMed ID: 11693197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total barley maiya alkaloids inhibit prolactin secretion by acting on dopamine D2 receptor and protein kinase A targets.
    Gong X; Tao J; Wang Y; Wu J; An J; Meng J; Wang X; Chen Y; Zou J
    J Ethnopharmacol; 2021 Jun; 273():113994. PubMed ID: 33711439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice.
    Green BD; Irwin N; Gault VA; Bailey CJ; O'Harte FP; Flatt PR
    J Endocrinol; 2005 May; 185(2):307-17. PubMed ID: 15845923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.
    Green BD; Irwin N; Duffy NA; Gault VA; O'harte FP; Flatt PR
    Eur J Pharmacol; 2006 Oct; 547(1-3):192-9. PubMed ID: 16945366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D2 receptor antagonist counteracts hyperglycemia and insulin resistance in diet-induced obese male mice.
    Vázquez-Carrillo DI; Ocampo-Ruiz AL; Báez-Meza A; Ramírez-Hernández G; Adán-Castro E; García-Rodrigo JF; Dena-Beltrán JL; de Los Ríos EA; Sánchez-Martínez MK; Ortiz MG; Martínez de la Escalera G; Clapp C; Macotela Y
    PLoS One; 2024; 19(4):e0301496. PubMed ID: 38635745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidiabetic effects of flavonoids from Sophora flavescens EtOAc extract in type 2 diabetic KK-ay mice.
    Yang X; Yang J; Xu C; Huang M; Zhou Q; Lv J; Ma X; Ke C; Ye Y; Shu G; Zhao P
    J Ethnopharmacol; 2015 Aug; 171():161-70. PubMed ID: 26051831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An amino acid mixture improves glucose tolerance and lowers insulin resistance in the obese Zucker rat.
    Bernard JR; Liao YH; Ding Z; Hara D; Kleinert M; Nelson JL; Ivy JL
    Amino Acids; 2013 Jul; 45(1):191-203. PubMed ID: 23525759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of in vitro dopamine synthesis in the median eminence of rats with haloperidol-induced hyperprolactinemia and bromocriptine-induced hypoprolactinemia.
    Arita J; Kimura F
    Endocrinology; 1986 Oct; 119(4):1666-72. PubMed ID: 3019639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice.
    Haluzik M; Colombo C; Gavrilova O; Chua S; Wolf N; Chen M; Stannard B; Dietz KR; Le Roith D; Reitman ML
    Endocrinology; 2004 Jul; 145(7):3258-64. PubMed ID: 15059949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice.
    Grefhorst A; van Dijk TH; Hammer A; van der Sluijs FH; Havinga R; Havekes LM; Romijn JA; Groot PH; Reijngoud DJ; Kuipers F
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E829-38. PubMed ID: 15941783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute exercise reverses TRB3 expression in the skeletal muscle and ameliorates whole body insulin sensitivity in diabetic mice.
    Matos A; Ropelle ER; Pauli JR; Frederico MJ; de Pinho RA; Velloso LA; De Souza CT
    Acta Physiol (Oxf); 2010 Jan; 198(1):61-9. PubMed ID: 19681769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
    Shah GV; Shyr SW; Grosvenor CE; Crowley WR
    Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.